Evidence map›Paper›PMID 41852090›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Interpretable CRAM‑Enhanced Lightweight Dual‑Branch CNN for Real‑Time Breast Cancer Histopathology in Internet‑of‑Medical‑Things Environments.

Roseline Oluwaseun Ogundokun, Rotimi-Williams Bello, Pius Adewale Owolawi, Rytis Maskeliūnas, Abdulsatar Abduljabbar Sultan

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roseline Oluwaseun OgundokunDepartment of Multimedia Engineering, Kaunas University of Technology, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-2592-2824
Rotimi-Williams BelloDepartment of Computer Systems Engineering, Tshwane University of Technology, Pretoria, South Africa.
Pius Adewale OwolawiDepartment of Computer Systems Engineering, Tshwane University of Technology, Pretoria, South Africa.
Rytis MaskeliūnasDepartment of Software Engineering, Kaunas University of Technology, Kaunas, Lithuania.
Abdulsatar Abduljabbar SultanBusiness Management Department, Catholic University in Erbil, Erbil, Kurdistan, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains a primary global health concern, with histopathological image analysis serving as the diagnostic gold standard. However, manual microscopy is time-consuming and often subjective. While deep learning offers a powerful solution, existing models are typically too complex and opaque for real-time use in Internet of Medical Things (IoMT) environments. To address this, we propose an interpretable and lightweight hybrid deep learning model that combines MobileNetV2 and EfficientNet-B0, enhanced by a novel contextual recurrent attention module (CRAM). CRAM refines fused features through attention-based weighting, improving focus on diagnostically relevant regions. The model achieved 99.9% classification accuracy and an AUC of 1.00, outperforming standalone baselines while remaining efficient (∼12 M parameters) and suitable for IoMT deployment. Interpretability is ensured through integrated Grad-CAM and SHAP analyses, which visually and quantitatively explain predictions by highlighting malignant tissue features that align with pathologist judgment. This balance of accuracy, efficiency, and transparency enables real-time, trustworthy diagnostics for resource-limited and point-of-care settings. Future work includes extending to multi-class tumor subtypes and clinical validation in real-world workflows. The proposed system represents a significant step toward making AI in digital pathology more accessible and explainable.

Indexed as

Breast NeoplasmsInternetInternet of ThingsConvolutional Neural NetworksDeep LearningFemaleHumansbreast cancerhistopathologyinternet‑of‑medical‑thingsinterpretablelightweight deep learningsmart diagnostic systems

Identifiers

PMID41852090
PMCPMC13155049

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.